FDA Archives | Page 79 of 79 | Medical Device News by Guided Solutions

Epineuron receives FDA 510(k) clearance for Evala Nerve Stimulator

May 14, 2026

Rivermark secures $20M in Series D for late-stage prostate device trial

May 14, 2026

SonoMind raises $23.5M for focused ultrasound-based depression therapy

May 13, 2026

Aurie wins FDA nod for reusable intermittent catheter system

May 12, 2026

Featured

Guided Solutions Celebrates 25 Years of Transforming Executive Search in MedTech

April 24, 2025

FDA clears NeurAxis’ self-inflating balloon device RED

January 30, 2025

Guided Solutions Appoints Marco Müller as New Managing Director Germany to Drive Strategic Growth

November 6, 2024

Guided Solutions Appoints Manu Chhokra as Managing Director for Switzerland

October 16, 2024

Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Epineuron receives FDA 510(k) clearance for Evala Nerve Stimulator

Aurie wins FDA nod for reusable intermittent catheter system

FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction

Microsure announces CE Mark approval and CEO transition

Reprieve Cardiovascular pilot study backs heart failure system

MMI completes first robotic-assisted procedure in Alzheimer’s patient

CVRx enrolls first patient in study of Barostim therapy for heart failure

Sensome reports positive findings for clot-sensing guidewire

Xtant Medical launches Trivium Shaped allograft for surgeries

Neuvotion to launch neurostim for post-stroke recovery

Reflow Medical launches next-gen microcatheters

Egg Medical unveils new radiation protection system for clinical use

Roche to acquire PathAI in $1.05B deal

Resmed enters merger agreement to acquire Noctrix Health for $340M

CareDx sharpens precision medicine focus with $260M Naveris acquisition

Stereotaxis announces definitive agreement to acquire Robocath

Rivermark secures $20M in Series D for late-stage prostate device trial

SonoMind raises $23.5M for focused ultrasound-based depression therapy

Apollo investment supports vVARDIS’s global Curodont expansion

Senseonics announces $80M public offering

Tag: FDA

Nanowear Receives FDA 510(k) Clearance for SimpleSENSE

Epineuron receives FDA 510(k) clearance for Evala Nerve Stimulator

Rivermark secures $20M in Series D for late-stage prostate device trial

SonoMind raises $23.5M for focused ultrasound-based depression therapy

Aurie wins FDA nod for reusable intermittent catheter system

Guided Solutions Celebrates 25 Years of Transforming Executive Search in MedTech

FDA clears NeurAxis’ self-inflating balloon device RED

Guided Solutions Appoints Marco Müller as New Managing Director Germany to Drive Strategic Growth

Guided Solutions Appoints Manu Chhokra as Managing Director for Switzerland